Related references
Note: Only part of the references are listed.Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
D. Ben-David et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Prevalence of infections in long-term care facilities: how to read it?
M. Marchi et al.
INFECTION (2012)
Containment of a Country-wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented Intervention
Mitchell J. Schwaber et al.
CLINICAL INFECTIOUS DISEASES (2011)
Klebsiella pneumoniae ESBL producers responsible for severe UTIs in a renal transplant unit
F. Gona et al.
INFECTION (2011)
Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy
S. Meier et al.
INFECTION (2011)
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
Y. Carmeli et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
V. Miriagou et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Potential Role of Active Surveillance in the Control of a Hospital-Wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae Infection
Debby Ben-David et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak
Y. Wiener-Well et al.
JOURNAL OF HOSPITAL INFECTION (2010)
Inappropriate Treatment of Catheter-Associated Asymptomatic Bacteriuria in a Tertiary Care Hospital
Matthew Cope et al.
CLINICAL INFECTIOUS DISEASES (2009)
Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Abraham Borer et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Patrice Nordmann et al.
LANCET INFECTIOUS DISEASES (2009)
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
Gopi Patel et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality
Mitchell J. Schwaber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections:: a matched case-control study
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients
Y. Bahagon et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2007)
Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid
David Raveh et al.
CHEMOTHERAPY (2007)
Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel
Shiri Navon-Venezia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Carbapenem resistance in Klebsielia pneumoniae not detected by automated susceptibility testing
Fred C. Tenover et al.
EMERGING INFECTIOUS DISEASES (2006)
Assessment of the clinical significance of production of extended-spectrum β-lactamases (ESBL) by Enterobacteriaceae
R. Henshke-Bar-Meir et al.
INFECTION (2006)
Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients
YG Kwak et al.
MICROBIAL DRUG RESISTANCE (2005)
Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae
CI Kang et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2004)
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City
PA Bradford et al.
CLINICAL INFECTIOUS DISEASES (2004)
Share Paper
